Pharmaceutical major Divi’s Laboratories reported its results for the July to September 2024 quarter in which it beat CNBC-TV18 poll estimates across parameters
Pharmaceutical major Divi’s Laboratories reported its results for the July to September 2024 quarter in which it beat CNBC-TV18 poll estimates across parameters